Please provide your email address to receive an email when new articles are posted on . Five-year all-cause death was higher in patients with undiagnosed HFpEF vs. those who received a ...
OXFORD, England, Aug. 2, 2023 /PRNewswire/ -- Ultromics, a pioneer in advancing heart failure diagnostics through artificial intelligence (AI), has received approval for NTAP from the Centers for ...
Many people with heart failure (HF) with preserved ejection fraction (HFpEF) may be undiagnosed. These patients face a higher mortality risk and would likely benefit from additional clinical attention ...
A new analysis, designed to shed light on the benefits of SGLT2 inhibition in patients who have heart failure with preserved ejection fraction (HFpEF), shows that dapagliflozin (Farxiga; AstraZeneca) ...
Screening for cardiac amyloidosis and excluding patients with cardiac amyloidosis from trials of new therapies for heart failure with preserved ejection fraction (HFpEF) may increase the chances of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback